Identification and characterization of novel IGFBP5 interacting protein: Evidence IGFBP5-IP is a potential regulator of osteoblast cell proliferation

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 3, 2006, Pages

  Amaar, Yousef G ^a   Tapia, Blanca ^a   Chen, Shin Tai ^a,b   Baylink, David J ^a,b   Mohan, Subburaman ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alternate splicing; Small interfering RNA; Yeast two hybrid screen

Indexed keywords

SMALL INTERFERING RNA; SOMATOMEDIN BINDING PROTEIN 5; CARRIER PROTEIN; COMPLEMENTARY DNA; IGFBP5 INTERACTING PROTEIN, HUMAN; IGFBP5-INTERACTING PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL LYSATE; CELL PROLIFERATION; CHROMOSOME 10; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; CHEMISTRY; CYTOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; METABOLISM; MOLECULAR GENETICS;

ANIMALIA;

AMINO ACID SEQUENCE; BASE SEQUENCE; CARRIER PROTEINS; CELL PROLIFERATION; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; MOLECULAR SEQUENCE DATA; OSTEOBLASTS;

EID: 33645455817     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00563.2004     Document Type: Article

References (32)

1. Amaar Y, Bala S, Baylink DJ, and Mohan S. Ras-association domain family 1 protein, RASS F1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation. J Bone Miner Res 20: 1430-1439, 2005.
2. Amaar YG, Thompson GR, Linkhart TA, Chen ST, Baylink DJ, and Mohan S. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J Biol Chem 277: 12053-12060, 2002.
3. Andress DL. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. Am J Physiol Endocrinol Metab 274: E744-E750, 1998.
4. Andress DL, Loop SM, Zapf J, and Kiefer MC. Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 195: 25-30, 1993.
5. Bauss F, Lang K, Dony C, and Kling G. The complex of recombinant human insulin-like growth factor-I (rhIGF-I) and its binding protein-5 (IGFBP-5) induces local bone formation in murine calvariae and in rat cortical bone after local or systemic administration. Growth Horm IGF Res 11: 1-9, 2001.
6. Brett D, Pospisil H, Valcarcel J, Reich J, and Bork P. Alternative splicing and genome complexity. Nat Genet 30: 29-30, 2002.
7. Elbashir S, Harborth J, Lendeckel W, Yalcin A, Webber K, and Tuschul T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498, 2001.
8. Fanayan S, Firth SM, Butt AJ, and Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-β (TGF-β) and the type II TGF-β receptor. J Biol Chem 275: 39146-39151, 2000.
9. Fields S and Song O. A novel genetic system to detect protein-protein interactions. Nature 340: 245-246, 1989.
10. Harborth J, Elbashir SM, Bechert K, Tuschl T, and Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114: 4557-4565, 2001.
11. 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90: 10553-10557, 1993.
12. Kuemmerle JF and Zhou H. Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways. J Biol Chem 277: 20563-20571, 2002.
13. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, and Cohen P. Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279: 469-476, 2004.
14. Leirdal M and Sioud M. Gene silencing in mammalian cells by preformed small RNA duplexes. Biochem Biophys Res Commun 295: 744-748, 2002.
15. Linkhart TA, Linkhart SG, MacCharles DC, Long DL, and Strong DD. Interleukin-6 messenger RNA expression and interleukin-6 protein secretion in cells isolated from normal human bone: regulation by interleukin-1. J Bone Miner Res 6: 1285-1294, 1991.
16. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, and Cohen P. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-α regulate transcriptional signaling and apoptosis. J Biol Chem 275: 33607-33613, 2000.
17. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, and Mohan S. Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107: 73-81, 2001.
18. Modrek B and Lee C. A genomic view of alternative splicing. Nat Genet 30: 13-9, 2002.
19. Mohan S and Baylink DJ. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res 45, Suppl 1: 59-62, 1996.
20. Mohan S and Baylink DJ. The IGF System, Molecular Biology, Physiology and Clinical Applications, edited by Rosenfeld RG and Roberts CT. Totowa, NJ: Humana, 1999, p. 457-496.
21. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, and Baylink DJ. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem 270: 20424-20431, 1995.
22. Oh Y, Muller HL, Lamson G, and Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem 268: 14964-14971, 1993.
23. 1 on programmed cell death through a p53 and IGF-independent mechanism. J Biol Chem 272: 12181-12188, 1997.
24. Richman C, Baylink DJ, Lang K, Dony C, and Mohan S. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140: 4699-4705, 1999.
25. Rosen CJ and Donahue LR. Insulin-like growth factors and bone: the osteoporosis connection revisited. Proc Soc Exp Biol Med 219: 1-7, 1998.
26. 26a. Salih DAM, Mohan S, Kasukawa Y, Tripathi G, Lovett FA, Anderson Carter NF, EJ, Wergedal JE, Baylink DJ, and Pell JM. Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology 146: 931-940, 2005.
27. Sambrook J, Fritsch EF, and Maniatis T. Molecular Cloning: A Laboratory Manual (2nd ed.). Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
28. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, and Baxter RC. Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the import in beta subunit. J Biol Chem 275: 23462-23470, 2000.
29. Schedlich LJ, Young TF, Firth SM, and Baxter RC. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D uman breast carcinoma cells. J Biol Chem 273: 18347-18352, 1998.
30. Shi Z, Xu W, Loechel F, Wewer UM, and Murphy LJ. ADAM 12, a disintegrin metalloproteinase, interacts with insulin-like growth factor-binding protein-3. J Biol Chem 275: 18574-18580, 2000.
31. Spagnoli A, Hwa V, Horton WA, Lunstrum GP, Roberts CT Jr, Chiarelli F, Torello M, and Rosenfeld RG. Antiproliferative effects of insulin-like growth factor-binding protein-3 in mesenchymal chondrogenic cell line RCJ31C518 Relationship to differentiation stage. J Biol Chem 276: 5533-5540, 2001.
32. Xia H, Mao Q, Paulson HL, and Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nat Biotechnol 20: 1006-1010, 2002.